Home Novartis Boost Seen in Fast Cancer Drug Review as Protection Ends: Health
 

Keywords :   


Novartis Boost Seen in Fast Cancer Drug Review as Protection Ends: Health

2013-05-06 03:24:00| Biotech - Topix.net

Just as Novartis AG 's best-selling medicines are losing patent protection, the company is poised to get a revenue boost from a U.S. program designed to speed life- saving therapies to patients with few treatment options.

Tags: health review fast protection

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.07Hurricane Beryl Graphics
05.07Hurricane Beryl Forecast Discussion Number 28
05.07Tropical Depression Aletta Graphics
05.07Hurricane Beryl Wind Speed Probabilities Number 28
05.07Hurricane Beryl Public Advisory Number 28
05.07Hurricane Beryl Forecast Advisory Number 28
05.07Tropical Depression Aletta Wind Speed Probabilities Number 5
05.07Tropical Depression Aletta Forecast Advisory Number 5
More »